By combining GWAS, EWAS, transcriptomics, metabolomics, immunophenotyping, and QTL mapping, along with MR, colocalization, transcriptome-wide association, and functional validation, we reveal SLC6A19 as a functionally relevant tumor suppressor. The gene discussed is SLC6A19; the disease is neoplasm.